PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Aluminium and magnesium and oxetacaine - Mucositis - chemotherapy / radiotherapy induced
PAD Profile : Aluminium and magnesium and oxetacaine - Mucositis - chemotherapy / radiotherapy induced
Keywords :
Antacid and oxetacaine
Traffic Light Status
Status 1 of 1.
Status :
Red
Important
Formulations :
- Oral suspension
Important Information :
As per guidance from St Luke's radiotherapy service for the management of immunotherapy-related adverse events: https://www.royalsurrey.nhs.uk/chemotherapy-policies-and-protocols?smbfolder=550
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
No committee recommendations returned.
Associated BNF Codes
01. Gastro-Intestinal System
01.01.01. Antacids and simeticone